Theradiag S.A.
PAR: ALTER.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Simon Daviere
- Employees
- 60
- Headquarters
- Marne-la-Vallée, France
- IPO year
- 2012
- Market cap
- €17.3M
- Website
- https://www.theradiag.com
Loading ALTER…
Loading profile data…Frequently asked questions about ALTER
What does Theradiag S.A. (ALTER.PA) do?
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the c...
Where does ALTER.PA trade?
Theradiag S.A. (ALTER.PA) trades on the Euronext Paris.
What sector is ALTER.PA in?
Theradiag S.A. (ALTER.PA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Theradiag S.A.?
Simon Daviere is the chief executive officer of Theradiag S.A. (ALTER.PA).
Where is Theradiag S.A. headquartered?
Theradiag S.A. is headquartered in France.
Does ALTER.PA pay a dividend?
Theradiag S.A. (ALTER.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALTER.PA go public?
Theradiag S.A. (ALTER.PA) completed its initial public offering in 2012.